… Association of the British Pharmaceutical Industry’s (ABPI) … to develop new medicines and vaccines. While the science … in drug evaluation” that could accelerate access to treatments while … testing MSD’s FDA-approved therapy Zolinza (vorinostat). AstraZeneca, …

… FDA orphan drug designation (ODD) for first-line treatment of … promise in early trials." Tinostamustine is … fusing the chemotherapy medications bendamustine and vorinostat. Through this … . National Center for Biotechnology Information. PubChem Compound …

… . Additionally, the study treatment produced a median progression … combination of pembrolizumab and vorinostat showed promising antitumor activity … , from the Department of Drug Development and Innovation (D3i … dose of study treatment. The trial’s primary end …

… drugs, can convert malignant cells into potent vaccines, … antimicrobial, anti-inflammatory, antidepressant, and anticancer effects.26 … valproic acid and vorinostat enhance trastuzumab-mediated … of nanotechnology in cancer treatment. Pharmaceutics. 2023;15(6): …

… initiative, stating, “We launched this grant to transform Gulf Medical University into … Using Machine Learning Drug Discovery/Precision Medicine RAK Medical and Health Sciences … in TNBC Precision Medicine Ajman University, UAE – Role of Vorinostat in Skin …

… medical imaging and cancer treatment. The excellent biocompatibility and drug … of Minocycline and Vorinostat Targets the Tumor Microenvironment … Based on Nano-Biotechnology in the Treatment of Glioma. … Gold Nanoparticles. Mol Pharmaceut. 2019;16:2430–2444 …

… potential to address key unmet medical needs in T-cell lymphomas … -100 has Orphan Drug Designation from the US FDA for all T … associated with standard care treatment vorinostat.  The Phase 1b trial remains open, with …

… in clinical cancer treatment, including vorinostat, romidepsin, and … Committee of China Pharmaceutical University (permit number … trials.16 In clinical practice, the HDAC inhibitor vorinostat … developing anti-cancer drugs. Comput. Struct. Biotechnol. J. …

… used as chemotherapeutic drugs for cancer treatment.149,150 … limit their potential as medicinal drug or formulation. Many … challenges, and future perspectives. Pharmaceuticals. 2025;18(2):207. … its combination with Vorinostat induces apoptotic-mediated cell …

… profiles of these medications, ultimately leading to improved treatment outcomes. Figure … clinical trials were isohydroxamic acid analogs.69 The FDA-approved drug vorinostat first … trial data for nano-based epigenetic drugs in breast cancer treatment …